(Total Views: 528)
Posted On: 04/10/2023 7:00:55 PM
Post# of 148891
Re: generactor #133937
generactor,
You noted that the 10-Q did not mention cancer, and nothing specific on it in the 10Q other than details of the TNBC data.
They had one sentence about cancer clinical developments and it is exactly the same sentence in the previous 10-Q (so nothing new):
The Company continues to identify the next steps in clinical development and is exploring potential business opportunities to continue the investigation of leronlimab for solid tumors in oncology based on data generated to date by the Company.
Do you think they have an oncology partner lined up but it is contingent on lifting the hold?
You noted that the 10-Q did not mention cancer, and nothing specific on it in the 10Q other than details of the TNBC data.
They had one sentence about cancer clinical developments and it is exactly the same sentence in the previous 10-Q (so nothing new):
The Company continues to identify the next steps in clinical development and is exploring potential business opportunities to continue the investigation of leronlimab for solid tumors in oncology based on data generated to date by the Company.
Do you think they have an oncology partner lined up but it is contingent on lifting the hold?
(1)
(0)Scroll down for more posts ▼
